Source: Patrick Trucchio 07/19/2023 The firm continues advancing its lead drug candidates, including those for anxiety and treatment-resistant...
The first half of 2023 has come to an end, and so far, this year has been just as action-packed as 2022. The first two quarters...
All the financial conflict disclosures from Psychedelics Science 2023 speakers, in one handy list. The post Every Disclosed Conflict of Interest at Psychedelic...
The world’s largest psychedelic conference kicked off with workshops and a dive into Burning Man-esque Deep Space. The post Report: Day 1 of MAPS’s...
Filament's CEO recently spoke with Executive Editor Debra Borchardt about the company's plans. The post Filament Health Wants to Standardize Natural Psilocybin...
Psychedelics Investor Christian Angermayer, TOMS Shoes Founder Blake Mycoskie, Burning Man CEO Marian Goodell, Neuroscientist Andrew Huberman, Comedians...
When it comes to investing, penny stocks often evoke a sense of intrigue and opportunity. These low-priced securities, typically traded under $5 per share,...
The Church of Psilomethoxin claims it’s the victim of “psychedelic capitalism,” but almost everything it claims is wrong. The post Church of Psilomethoxin,...
Senate SAFE hearing; CT psilocybin decrim passes; NH rejects legalization; Top WI senator talks marijuana; DE rep’s cannabis advice for other states...
The company's net loss ticked down after March labor cuts. The post Atai Life Sciences Remains Bullish on Mental Health Drug Trials Despite Cash Burn appeared...